Back
S&T Bancorp, Inc. 10K Form
Buy
67
STBA
S&T Bancorp, Inc.
Last Price:
$40.10
Seasonality Move:
0.96%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-02 | 10Q | STBA/S&T Bancorp, Inc. Quarterly |
| 2023-11-03 | 10Q | STBA/S&T Bancorp, Inc. Quarterly |
| 2023-08-03 | 10Q | STBA/S&T Bancorp, Inc. Quarterly |
| 2023-05-05 | 10Q | STBA/S&T Bancorp, Inc. Quarterly |
| 2022-11-02 | 10Q | STBA/S&T Bancorp, Inc. Quarterly |
| 2022-08-03 | 10Q | STBA/S&T Bancorp, Inc. Quarterly |
Receive STBA News And Ratings
See the #1 stock for the next 7 days that we like better than STBA
STBA Financial Statistics
Sales & Book Value
| Annual Sales: | $564.8M |
|---|---|
| Cash Flow: | $39.9M |
| Price / Cash Flow: | 10.47 |
| Annual Sales: | $38.47 |
| Price / Book: | 1.04 |
Profitability
| EPS (TTM): | 3.46180 |
|---|---|
| Net Income (TTM): | $133.3M |
| Gross Margin: | $0 |
| Return on Equity: | 9.4% |
| Return on Assets: | 1.37% |
S&T Bancorp, Inc. Earnings Forecast
Key S&T Bancorp, Inc. Financial Ratios
-
The Gross Profit Margin over the past 36 years for STBA is 0.00%.
-
The Selling, General & Administrative Expenses for STBA have been equal to 0.00% of Gross Profit Margin.
-
The Interest Expense is 14.59% of Operating Income.
-
The Net Earning history of STBA is 23.24% of Total Revenues.
-
Per Share Earnings over the last 36 years have been positive in 28 years.
S&T Bancorp, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Banks |
| Sector: | Financials |
| Current Symbol: | STBA |
| CUSIP: | 783859 |
| Website: | stbancorp.com |
Debt
| Debt-to-Equity Ratio: | 0.16 |
|---|---|
| Current Ratio: | 0.05 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 11.78 |
|---|---|
| Forward P/E Ratio: | 11.41 |
STBA Technical Analysis vs Fundamental Analysis
Buy
67
S&T Bancorp, Inc. (STBA)
is a Buy
Is S&T Bancorp, Inc. a Buy or a Sell?
-
S&T Bancorp, Inc. stock is rated a BuyThe current S&T Bancorp, Inc. [STBA] share price is $40.13. The Score for STBA is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.